(MIRM) Mirum Pharmaceuticals - Performance 80.7% in 12m
Compare MIRM with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
73.58%
#5 in Group
Rel. Strength
93.19%
#543 in Universe
Total Return 12m
80.67%
#17 in Group
Total Return 5y
148.16%
#13 in Group
P/E -
(?) Percentile in Group
P/E Forward 39.7
79th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 0.43%
82th Percentile in Group
12m Total Return: MIRM (80.7%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: MIRM vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MIRM
| Total Return (including Dividends) | MIRM | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 15.06% | 11.81% | 13.81% |
| 3 Months | -10.34% | -13.61% | -6.30% |
| 12 Months | 80.67% | -12.29% | 10.65% |
| 5 Years | 148.16% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | MIRM | XBI | S&P 500 |
| 1 Month | 71.0% | 72.9% | 83% |
| 3 Months | -78.2% | -83% | -75.3% |
| 12 Months | 71.0% | -51.6% | 50.1% |
| 5 Years | 84.0% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #141 | 2.91% | 1.09% |
| 3 Month | #77 | 3.78% | -4.32% |
| 12 Month | #18 | 106% | 63.3% |
| 5 Years | #12 | 230% | 19.4% |
FAQs
Does MIRM Mirum Pharmaceuticals outperforms the market?
Yes,
over the last 12 months MIRM made 80.67%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months MIRM made -10.34%, while XBI made -13.61%.
Over the last 3 months MIRM made -10.34%, while XBI made -13.61%.
Performance Comparison MIRM vs Indeces and Sectors
MIRM vs. Indices MIRM is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 3.01% | 1.25% | 12.7% | 70.0% |
| US NASDAQ 100 | QQQ | 2.82% | -2.30% | 12.4% | 69.0% |
| US Dow Jones Industrial 30 | DIA | 2.60% | 5.07% | 12.9% | 73.0% |
| German DAX 40 | DAX | 3.03% | 0.10% | -13.6% | 55.0% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 0.83% | 3.23% | 11.9% | 73.3% |
| Hongkong Hang Seng | HSI | -0.16% | -4.87% | 4.29% | 67.0% |
| India NIFTY 50 | INDA | 7.93% | 10.2% | 12.2% | 80.9% |
| Brasil Bovespa | EWZ | 1.96% | -2.18% | 3.95% | 89.0% |
MIRM vs. Sectors MIRM is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.37% | 1.65% | 5.59% | 59.1% |
| Consumer Discretionary | XLY | 2.63% | 0.83% | 13.6% | 66.4% |
| Consumer Staples | XLP | 3.87% | 8.47% | 5.72% | 71.6% |
| Energy | XLE | 3.19% | 8.30% | 19.2% | 90.1% |
| Financial | XLF | 1.91% | 1.54% | 5.55% | 58.2% |
| Health Care | XLV | 6.02% | 14.2% | 17.6% | 84.7% |
| Industrial | XLI | 1.32% | -1.76% | 11.2% | 69.7% |
| Materials | XLB | 3.21% | 1.50% | 17.5% | 85.9% |
| Real Estate | XLRE | 4.33% | 3.52% | 11.9% | 65.2% |
| Technology | XLK | 1.93% | -6.16% | 15.5% | 73.6% |
| Utilities | XLU | 2.96% | 5.47% | 4.99% | 63.2% |
| Aerospace & Defense | XAR | 1.03% | -6.10% | 1.15% | 53.3% |
| Biotech | XBI | 9.60% | 3.25% | 32.8% | 93.0% |
| Homebuilder | XHB | 2.54% | 3.58% | 25.8% | 88.2% |
| Retail | XRT | 1.11% | 0.41% | 16.9% | 82.2% |